Skip to main content
. 2022 Mar 17;12:833680. doi: 10.3389/fonc.2022.833680

Table 5.

Validation of a XGboost model for predicting BC in MRI BiRADS 4.

Biopsy XGboost model, n (%)
Benign Malignant
Benign (n=25) 22 (88%) 3 (12%)
Malignant (n=25) 4 (16%) 21 (84%)